Delivery Order SPE2DX22D0099-SPE2D825FAP7D
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $14,013.99 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $6,146.83 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under a larger indefinite delivery vehicle and requires performance at the awardee's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $9,883.05 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract deliverables fall under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,367.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $757,404.75 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor based in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 21, 2025, represents a competitive award with no set-aside designation and is scheduled for ultimate completion by July 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,483.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order was placed with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $18,183.90 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction for pharmaceutical and medical supplies to support federal healthcare operations. The contractor, headquartered in Conshohocken, Pennsylvania, is a...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $23,628.39 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,361.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,895.86 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award utilizes firm fixed pricing with no set-aside designation, reflecting...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D825FAP7DDelivery Order
The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $10,750.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued with no set-aside designation, represents a competitively awarded contract under the Defense Logistics Agency's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor supplying a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract performance demonstrates consistent capability to meet federal procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 7/21/25 |